Evofem Biosciences, Inc.EVFMOTCMARKET
Loading
Asset Growth Under PressureDecelerating
Percentile Rank64
Year-over-Year Change
Year-over-year total asset growth rate
Latest
-4.00%
↓ 107% vs avg
Percentile
P64
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
60.61%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -4.00% |
| Q2 2025 | 11.69% |
| Q1 2025 | -45.87% |
| Q4 2024 | -0.64% |
| Q3 2024 | 179.99% |
| Q2 2024 | 4.06% |
| Q1 2024 | -22.14% |
| Q4 2023 | -20.78% |
| Q3 2023 | -5.34% |
| Q2 2023 | -45.94% |
| Q1 2023 | 3.46% |
| Q4 2022 | -40.49% |
| Q3 2022 | -20.93% |
| Q2 2022 | 54.68% |
| Q1 2022 | -18.68% |
| Q4 2021 | -36.95% |
| Q3 2021 | -38.00% |
| Q2 2021 | 16.35% |
| Q1 2021 | -15.01% |
| Q4 2020 | -2.10% |
| Q3 2020 | -16.83% |
| Q2 2020 | 763.25% |
| Q1 2020 | -44.71% |
| Q4 2019 | -27.43% |
| Q3 2019 | -28.35% |
| Q2 2019 | 1582.59% |
| Q1 2019 | -19.35% |
| Q4 2018 | -73.31% |
| Q3 2018 | -42.58% |
| Q2 2018 | 191.03% |
| Q1 2018 | 118.32% |
| Q4 2017 | -34.06% |
| Q3 2017 | -23.95% |
| Q2 2017 | -23.48% |
| Q1 2017 | -16.26% |
| Q4 2016 | -15.71% |
| Q3 2016 | 0.00% |